Govt Tightens Cough Syrup Rules, Prescription Needed For More Formulations

The government has tightened regulations governing the sale of cough syrups by withdrawing a key exemption under Schedule K of the Drugs Rules. The move means that more cough syrup formulations may now require a doctor's prescription before purchase, particularly those containing controlled ingredients such as codeine. Authorities say the decision is aimed at preventing misuse and strengthening oversight of drug sales. The change follows concerns over the safety and quality of certain India-made cough syrups that were linked to deaths and health complications in some overseas markets. However, officials have clarified that this is not a blanket ban on all cough syrups. The requirement for a prescription will depend on the composition and regulatory classification of each formulation.